Dr. Truong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Taussig Cancer Institute 10201 Carnegie Aveca60
Cleveland, OH 44195Phone+1 216-445-4623Fax+1 216-444-9464
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2010 - 2012
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2006 - 2009
- Medical University of South CarolinaClass of 2006
Certifications & Licensure
- CA State Medical License 2010 - 2026
- OH State Medical License 2023 - 2025
- MA State Medical License 2009 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 222 citationsNeoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost
The New England Journal of Medicine. 2023-03-02 - 32 citationsSystemic Therapy for Melanoma: ASCO Guideline Update.Rahul Seth, Sanjiv S Agarwala, Hans Messersmith, Krishna C Alluri, Paolo A Ascierto
Journal of Clinical Oncology. 2023-10-20 - 30 citationsAdjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma.Kenneth F. Grossmann, Megan Othus, Sapna Pradyuman Patel, Ahmad A. Tarhini, Vernon K. Sondak
Cancer Discovery. 2021-11-11
Press Mentions
- Anco Board Elects Millie Das, Md, to Lead Oncology AssociationSeptember 20th, 2023
- How New Immunotherapy Is Helping to Treat MelanomaAugust 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: